SEC Filings

SEC Filings

Filing date	Description	Form	View
Feb 12, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-030591.pdf 0001193125-10-030591.rtf 0001193125-10-030591.xls
Feb 11, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-008322.pdf 0001181431-10-008322.rtf
Feb 10, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001181431-10-008116.pdf 0001181431-10-008116.rtf 0001181431-10-008116.xls
Feb 02, 2010	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000950005-10-000025.pdf 0000950005-10-000025.rtf 0000950005-10-000025.xls
Jan 28, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-014900.pdf 0001193125-10-014900.rtf 0001193125-10-014900.xls
Jan 28, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-015604.pdf 0001193125-10-015604.rtf 0001193125-10-015604.xls
Jan 21, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-009752.pdf 0001193125-10-009752.rtf 0001193125-10-009752.xls
Jan 20, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-008571.pdf 0001193125-10-008571.rtf 0001193125-10-008571.xls
Jan 20, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-003730.pdf 0001181431-10-003730.rtf
Jan 20, 2010	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-10-003731.pdf 0001181431-10-003731.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE